Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2000
04/06/2000WO2000018835A1 Modified starch film compositions
04/06/2000WO2000018821A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
04/06/2000WO2000018554A1 A method for producing a layered product
04/06/2000WO2000018447A2 Multiplex drug delivery system suitable for oral administration
04/06/2000WO2000018406A1 Oral dosage formulations comprising (2s,3s,5r) -2-(3,5- difluorophenyl) -3,5-dimethyl -2-morpholinol and an effective stabilizing amount of alginic acid
04/06/2000WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000WO2000018401A1 Antimycotic drug composition
04/06/2000WO2000018396A1 HMG-CoA REDUCTASE INHIBITOR-CONTAINING PREPARATIONS
04/06/2000WO2000018393A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
04/06/2000WO2000018387A2 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000WO2000018380A1 Prevention and treatment of parodontitis
04/06/2000WO2000018379A2 Pharmaceutical preparation for use in a method to abate the use of tobacco by humans
04/06/2000WO2000018378A1 Sustained release hydromorphone formulations exhibiting bimodal characteristics
04/06/2000WO2000018377A1 Enteric and colonic delivery using hpmc capsules
04/06/2000WO2000018376A1 Aqueous enteric coating composition with low gastric permeability
04/06/2000WO2000018375A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration
04/06/2000WO2000018374A1 Controlled release nanoparticulate compositions
04/06/2000WO2000018373A1 Core tablet for controlled release of gliclazide after oral administration
04/06/2000WO2000018372A1 Grains for oral preparations
04/06/2000WO2000018371A1 Proteinic drug delivery system using membrane mimetics
04/06/2000WO2000018370A2 Liquid pharmaceutical for oral delivery
04/06/2000WO2000018369A1 Iontophoretic devices comprising piperidin derivatives
04/06/2000WO2000018366A1 Oral composition with an improved teeth whitening effect
04/06/2000WO2000018365A2 Fast dissolving orally consumable films
04/06/2000WO2000018339A1 Methods and apparatus for improved administration of pharmaceutically active compounds
04/06/2000WO2000018338A1 Methods and apparatus for improved administration of fentanyl and sufentanil
04/06/2000WO2000018326A1 Flexible transmyocardial implant angiogenesis
04/06/2000WO2000018316A2 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
04/06/2000WO2000018259A1 Nutritional and pharmaceutical compositions
04/06/2000WO2000018254A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability
04/06/2000WO1999065452A3 Hydrogels of water soluble polymers crosslinked by protein domains
04/06/2000WO1999062510A3 Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
04/06/2000WO1999061056A3 Methods and products for inducing mucosal immunity
04/06/2000WO1999040113A3 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
04/06/2000DE19845358A1 Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe Excessive dosage forms with controlled release
04/06/2000DE19844903A1 Use of water-soluble and water-dispersible polyalkylene oxide and polyglycerol containing polymerizates as pharmaceutical coating agents, binders and film-formers
04/06/2000CA2345638A1 Oral dosage formulations comprising (2s,3s,5r) -2-(3,5- difluorophenyl) -3,5-dimethyl -2-morpholinol and an effective stabilizing amount of alginic acid
04/06/2000CA2345612A1 Anti-fungal composition
04/06/2000CA2345306A1 Nutritional and pharmaceutical compositions
04/06/2000CA2345075A1 Mixed liposome drug delivery system using membrane mimetics
04/06/2000CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000CA2344292A1 Modified starch film compositions
04/06/2000CA2344050A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000CA2343811A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000CA2342981A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
04/06/2000CA2340130A1 Liquid pharmaceutical for oral delivery
04/06/2000CA2249675A1 A novel composition containing cyclosporin
04/05/2000WO2000024423A1 Sustained-release particles
04/05/2000EP0990450A2 Pharmaceutical implants
04/05/2000EP0990438A1 Heat stable antacid and antigas suspensions
04/05/2000EP0990437A1 Aerosol compositions
04/05/2000EP0990425A2 Substance delivery device
04/05/2000EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds
04/05/2000EP0989849A2 Therapeutic nanospheres
04/05/2000EP0989848A2 Film-coated tablet for improved upper gastrointestinal tract safety
04/05/2000EP0989847A1 Anti-tumoral therapy agent
04/05/2000EP0989846A2 Non-irritating cosmetic and pharmaceutical compositions
04/05/2000EP0989825A2 Method and apparatus for administration of substances by ultrasound
04/05/2000EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
04/05/2000EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
04/05/2000EP0741689B1 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
04/05/2000CN1249690A Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
04/05/2000CN1249687A Compositions and methods for reducing ocular hypertension
04/05/2000CN1249686A Paroxetine compositions
04/05/2000CN1249679A Transdermal therapeutic system
04/05/2000CN1249181A Universal medicinal cream and its preparing process
04/05/2000CN1249177A Activator administration system contg. composition based on salicylic deriv. in film structure, and its use
04/05/2000CN1249176A Soft chew tablet
04/05/2000CN1051019C Stasis eliminating and pulse-beat invigorating capsule
04/05/2000CN1051015C Anticancer health-care tea
04/05/2000CN1051014C Ginseng and aconite injection and its preparing method
04/05/2000CN1051011C Instant granule for strengthening body resistance to brain tumor
04/05/2000CN1051006C Contrast medium for cholecystography and cholangiography
04/05/2000CN1051002C Chinese medicinal herbs composition for treating pulmonary tuberculosis with cavity
04/05/2000CN1051001C Fine powder of fruit of Chinese wolfberry, and oil made therefrom
04/05/2000CN1050993C Drug with effect of resisting and preventing tension and intelligence promoting
04/05/2000CA2347104A1 Sustained-release particles
04/04/2000US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
04/04/2000US6046277 Coating composition contains polyvinyl acetate, a n-vinylpyrrolidone containing polymer, a water soluble or swellable substance, a water insoluble dusting agent and optionally additives; controlled release
04/04/2000US6046244 Composition comprising prostaglandin e1, skin penetration enhancer, polysaccharide gum, lipophilic compound, acidic buffer system
04/04/2000US6046240 Methods for treating female sexual dysfunction
04/04/2000US6046230 Stable injection formulation containing paclitaxel
04/04/2000US6046188 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
04/04/2000US6046187 Use of glucocorticosteroids in methods and formulations for prolonging and/or reactivating local anesthesia or local anesthesia previously induced by a local anesthetic agent
04/04/2000US6046179 Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
04/04/2000US6046177 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
04/04/2000US6046163 Cyclosporin formulation
04/04/2000US6046022 Methods and compositions employing red rice fermentation products
04/04/2000US6045855 Electrostatic coating of small falling objects
04/04/2000US6045830 Thermally drying the microcapsules at a temperature just above glass transition temperature of homopolymer or copolymer of lactic acid/glycolic acid encapsulating bioactive ingredient
04/04/2000US6045829 Having increased rate and uniformity of absorption in vivo
04/04/2000US6045828 Mixture of crystalline, hydrophilic carrier and freeze dried, single phase particles comprising a biologically active component and a lipid component having a phase transition temperature below 37 degrees c
04/04/2000US6045827 Treatment of equine laminitis
04/04/2000US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis
04/04/2000US6045825 Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit
04/04/2000US6045824 Sustained-release liposomal anesthetic compositions
04/04/2000US6045823 Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
04/04/2000US6045822 Protein kinase c inhibitor, antitumor agent having stability in blood
04/04/2000US6045821 Chelate compound immobilized on membrane whereby the chelating agent comprises a macrocyclic chelant moiety with a lipophilic membrane associating moiety attached to ring atom; organometallic compound medical diagnostic agents
04/04/2000US6045820 Iodinated strong base anion exchange resin antiseptic particles attached to a carrier material whereby the antiseptic leaves no halogen residue in sterilized fluid or bodily wound sites
1 ... 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 ... 2991